Sarcoid-like reactions in patients receiving modern melanoma treatment.

about

Sarcoid-like reactions in patients receiving modern melanoma treatment.

Item

http://www.wikidata.org/entity/Q54982896

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Sarcoid-like reactions in patients receiving modern melanoma treatment.

@en

Sarcoid-like reactions in patients receiving modern melanoma treatment.

@nl

type

Item

label

Sarcoid-like reactions in patients receiving modern melanoma treatment.

@en

Sarcoid-like reactions in patients receiving modern melanoma treatment.

@nl

prefLabel

Sarcoid-like reactions in patients receiving modern melanoma treatment.

@en

Sarcoid-like reactions in patients receiving modern melanoma treatment.

@nl

P1476

Sarcoid-like reactions in patients receiving modern melanoma treatment

@en

P2093

Anna L Frauchiger

http://www.w3.org/2001/XMLSchema#string

Daniel Franzen

http://www.w3.org/2001/XMLSchema#string

Florentia Dimitriou

http://www.w3.org/2001/XMLSchema#string

Jivko Kamarachev

http://www.w3.org/2001/XMLSchema#string

Joanna Mangana

http://www.w3.org/2001/XMLSchema#string

Marjam Barysch

http://www.w3.org/2001/XMLSchema#string

Mirjam C Naegeli

http://www.w3.org/2001/XMLSchema#string

Mirjana Urosevic-Maiwald

http://www.w3.org/2001/XMLSchema#string

Reinhard Dummer

http://www.w3.org/2001/XMLSchema#string

Simone M Goldinger

http://www.w3.org/2001/XMLSchema#string

P2860

Sarcoidosis in Melanoma Patients: Case Report and Literature Review

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma

Nivolumab in previously untreated melanoma without BRAF mutation

Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature.

Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.

The incidence of malignant tumours in patients with respiratory sarcoidosis.

The immune paradox of sarcoidosis and regulatory T cells.

Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes.

P304

230-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CMR.0000000000000437

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ralph P Braun

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29485531

http://www.w3.org/2001/XMLSchema#string

P932

5929490

http://www.w3.org/2001/XMLSchema#string